Meeting
2022 ASCO Quality Care Symposium
Sociodemographic predictors of cannabis use among patients with cancer residing in states with legalized cannabis.
Authors
Talya Salz
Memorial Sloan Kettering Cancer Center, New York, NY
Talya Salz, Akriti Mishra Meza, Fumiko Chino, Jun J. J. Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Maribel Hernandez, Deborah Korenstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Symptom Prevention, Assessment, and Management
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 299)
DOI
10.1200/JCO.2022.40.28_suppl.299
Abstract #
299
Poster Bd #
G21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Impact of acute therapeutic toxicities on anxiety during radiotherapy among Chinese patients with newly diagnosed nonmetastatic head and neck cancer: A cross-sectional study.
First Author: Fengyan Li
Poster
2024 ASCO Annual Meeting
When pain management meets harm reduction: Patients with cancer navigate the opioid crisis—2016 to 2020 National Inpatient Sample analysis.
First Author: Himal Kharel
Poster
2024 ASCO Genitourinary Cancers Symposium
A novel cardiovascular disease risk score for prediction of atherosclerotic disease events in men with prostate cancer.
First Author: Nickolas Stabellini
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world use of pemigatinib (pemi) for cholangiocarcinoma (CCA) among racial and ethnic minorities in the United States.
First Author: Richard D. Kim